Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-032214
Filing Date
2021-03-04
Accepted
2021-03-05 08:13:39
Documents
50
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm217248d1_10k.htm 10-K 677286
2 EXHIBIT 4.2 tm217248d1_ex4-2.htm EX-4.2 55232
3 EXHIBIT 31.1 tm217248d1_ex31-1.htm EX-31.1 12755
4 EXHIBIT 31.2 tm217248d1_ex31-2.htm EX-31.2 12730
5 EXHIBIT 32.1 tm217248d1_ex32-1.htm EX-32.1 4691
6 EXHIBIT 32.2 tm217248d1_ex32-2.htm EX-32.2 5007
  Complete submission text file 0001104659-21-032214.txt   2695492

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA raca-20201231.xsd EX-101.SCH 35366
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE raca-20201231_cal.xml EX-101.CAL 18879
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE raca-20201231_def.xml EX-101.DEF 110509
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE raca-20201231_lab.xml EX-101.LAB 252738
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE raca-20201231_pre.xml EX-101.PRE 193933
12 XBRL INSTANCE DOCUMENT raca-20201231.xml EX-101.INS 315808
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 617-778-2500
Therapeutics Acquisition Corp. (Filer) CIK: 0001811764 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39373 | Film No.: 21716592
SIC: 6770 Blank Checks